TrademarkDir
ANDOSAN
LIVE

Serial Number

79364782

Owner

Mycotech Pharma AS

Attorney

Christian D. Abel

Filing Date

Feb 17, 2023

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

ANDOSAN Trademark

Serial Number: 79364782 • Registration: 7383414

ANDOSAN is a trademark filed by Mycotech Pharma AS on February 17, 2023. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Mycotech Pharma AS

Lilleakerveien 2B

Entity Type: 99

Trademark Details

Filing Date

February 17, 2023

Registration Date

May 14, 2024

Published for Opposition

February 27, 2024

Goods & Services

Pharmaceutical preparations and natural remedy preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; nutraceutical preparations for therapeutic or medical purposes, namely, nutraceuticals for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; dietary and nutritional supplements; health food supplements for humans; nutraceuticals for use as dietary supplements

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Sep 26, 2025 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Nov 30, 2024 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Nov 8, 2024 FICS
FINAL DISPOSITION PROCESSED
Nov 8, 2024 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 14, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 14, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
May 14, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 4, 2024 NPUB
NOTIFICATION PROCESSED BY IB
Feb 27, 2024 GPNX
PUBLISHED FOR OPPOSITION
Feb 27, 2024 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 7, 2024 OPNS
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 7, 2024 NPUB
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 7, 2024 NONP
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Feb 7, 2024 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 18, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 19, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 19, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 19, 2023 TROA
REFUSAL PROCESSED BY IB
Dec 19, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 29, 2023 RFCS
REFUSAL PROCESSED BY MPU
Nov 29, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 28, 2023 RFCR
NON-FINAL ACTION WRITTEN
Nov 27, 2023 CNRT
ASSIGNED TO EXAMINER
Nov 16, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 14, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 10, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 9, 2023 REPR

Related Trademarks